Neurocrine Biosciences, Inc. (NBIX)
128.13
-1.51
(-1.16%)
USD |
NASDAQ |
Mar 06, 16:00
128.18
+0.05
(+0.04%)
After-Hours: 20:00
Neurocrine Biosciences SG&A Expense (TTM) : 1.156B for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Glaukos Corp. | 331.75M |
| Edgewise Therapeutics, Inc. | 40.02M |
| Nuvalent, Inc. | 107.34M |
| Marker Therapeutics, Inc. | 4.365M |
| CapsoVision, Inc. | 10.68M |